Literature DB >> 28442685

Deep Sclerectomy.

Sylvain Roy, André Mermoud.   

Abstract

Filtering surgery evolved from the classic trabeculectomy, in which penetration into the anterior chamber is a necessary step, toward nonpenetrating deep sclerectomy. The first procedure presents several serious complications, such as durable hypotony, hyphema, flat anterior chamber, choroidal detachment, endophthalmitis, and surgery-induced cataract. To avoid such drawbacks, a novel nonpenetrating technique was designed to improve the predictability of the intraocular pressure (IOP)-lowering action, while reducing the incidence of the immediate postoperative complications encountered with the penetrating method. This surgery works by building up new outflow pathways for the drainage of the aqueous humor while maintaining the integrity of the anterior chamber. Deep sclerectomy acts at the bulk of main resistance to aqueous humor egress, located at the juxtacanalicular meshwork and at the inner wall of Schlemm's canal. It consists of dissection of these two structures while keeping a thin filtering membrane through which aqueous humor is drained. The membrane prevents overfiltration and ensures a reproducible postoperative IOP. This surgery is indicated for most glaucomas, with the exception of angle closure and neovascular cases. The procedure consists in opening the conjunctiva and Tenon's capsule and creating a 5 × 5-mm limbus-based superficial scleral flap. A deeper scleral flap measuring about 4 × 4 mm is dissected and the roof of Schlemm's canal is removed. A space maintainer is inserted and the flap and conjunctiva are closed. Results after 10 years are good, with an IOP of 12.2 ± 4.7 mmHg and an overall success rate of 77.6% with few complications.
© 2017 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2017        PMID: 28442685     DOI: 10.1159/000458484

Source DB:  PubMed          Journal:  Dev Ophthalmol        ISSN: 0250-3751


  8 in total

1.  Flap-sparing canaloplasty: a modified approach to Schlemm's canal.

Authors:  Matthias C Grieshaber; Ané Pienaar; Robert Stegmann
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2019-05-06       Impact factor: 3.117

2.  [Results of filtering trabeculotomy (FTO) compared to conventional trabeculectomy (TE)-a matched case control study].

Authors:  Caroline Maria Glatzel; Ágnes Patzkó; Juliane Matlach; Franz Grehn
Journal:  Ophthalmologe       Date:  2021-03-29       Impact factor: 1.059

3.  Nonpenetrating Deep Sclerectomy for Progressive Glaucoma: Long-term (5-year) Follow-up of Intraocular Pressure Control and Visual Field Survival.

Authors:  Grant Slagle; Sylvia L Groth; Mario Montelongo; William E Sponsel
Journal:  J Curr Glaucoma Pract       Date:  2020 Jan-Apr

4.  XEN-Augmented Deep Sclerectomy: Step-by-step Description of a Novel Surgical Technique for the Management of Open-angle Glaucoma.

Authors:  Laëtitia J Niegowski; Kevin Gillmann; J-M Baumgartner
Journal:  J Curr Glaucoma Pract       Date:  2021 Sep-Dec

5.  Viscocanalostomy and combined phacoemulsification with viscocanalostomy: A five-year follow-up.

Authors:  Conor M Lyons; Daniela Oehring; Divya Mathews
Journal:  Indian J Ophthalmol       Date:  2022-01       Impact factor: 1.848

6.  Outcomes of Deep Sclerectomy following Failed XEN Gel Stent Implantation in Open-Angle Glaucoma: A Prospective Study.

Authors:  Giorgio Enrico Bravetti; Kevin Gillmann; Harsha L Rao; André Mermoud; Kaweh Mansouri
Journal:  J Clin Med       Date:  2022-08-16       Impact factor: 4.964

7.  Ciliochoroidal effusion and its association with the outcomes of micropulse transscleral laser therapy in glaucoma patients: a pilot study.

Authors:  Sunee Chansangpetch; Natnaree Taechajongjintana; Kitiya Ratanawongphaibul; Rath Itthipanichpong; Anita Manassakorn; Visanee Tantisevi; Prin Rojanapongpun; Shan C Lin
Journal:  Sci Rep       Date:  2022-09-30       Impact factor: 4.996

8.  A comparison of the 1-year surgical outcomes of ab externo trabeculotomy and microhook ab interno trabeculotomy using propensity score analysis.

Authors:  Sotaro Mori; Yusuke Murai; Kaori Ueda; Mari Sakamoto; Takuji Kurimoto; Yuko Yamada-Nakanishi; Makoto Nakamura
Journal:  BMJ Open Ophthalmol       Date:  2020-03-05
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.